col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


63 Results       Page 1

 [1] 
Frontiers Media SA: Frontiers in Chemistry
  original article Date Title Authors   All Authors
1 [GO] 2024―Apr―29 Modulation in serum and hematological parameters as a prognostic indicator of COVID-19 infection in hypertension, diabetes mellitus, and different cardiovascular diseases Muhammad Ishtiaq Jan, Riaz Anwar Khan, Naeem Khan, Syed Muhammad Iftikhar, Sajid Ali, M. I. Khan, et al. (+5)
2 [GO] 2024―Feb―22 Harnessing Brazilian biodiversity database: identification of flavonoids as potential inhibitors of SARS-CoV-2 main protease using computational approaches and all-atom molecular dynamics simulation João Augusto Pereira da Rocha, Renato Araújo da Costa, Andreia do Socorro Silva da Costa, Elaine Cristina Medeiros da Rocha, Anderson José Bahia Gomes, Alencar Kolinski Machado, et al. (+3)
3 [GO] 2024―Jan―16 Elucidating the binding mechanism of SARS-CoV-2 NSP6-TBK1 and structure-based designing of phytocompounds inhibitors for instigating the host immune response Muhammad Suleman, Iqra Ishaq, Haji Khan, Safir Ullah khan, Rehana Masood, Norah A. Albekairi, et al. (+2)
4 [GO] 2023―Oct―24 Exploring the disruption of SARS-CoV-2 RBD binding to hACE2 Camryn Carter, Justin Airas, Haley Gladden, Bill R. Miller, Carol A. Parish
5 [GO] 2023―Sep―26 Exploration of phenolic acid derivatives as inhibitors of SARS-CoV-2 main protease and receptor binding domain: potential candidates for anti-SARS-CoV-2 therapy Nusrat Shafiq, Aiman Mehroze, Warda Sarwar, Uzma Arshad, Shagufta Parveen, Maryam Rashid, et al. (+6)
6 [GO] 2023―May―18 Raman and fourier transform infrared spectroscopy techniques for detection of coronavirus (COVID-19): a mini review Qiuqi Zhang, Lei Zhao, Guoliang Qi, Xiaoru Zhang, Cheng Tian
7 [GO] 2023―Apr―20 Increased inflammatory cytokines and oxidative stress enhanced antibody production in breast and prostate cancer patients with COVID-19 related depression Naif K. Binsaleh, Subuhi Sherwani, Reem Eltayeb, Husam Qanash, Abdulrahman S. Bazaid, Maryam Althobiti, et al. (+2)
8 [GO] 2023―Mar―13 PVC containing silver nanoparticles with antimicrobial properties effective against SARS-CoV-2 Daniel J. da Silva, Guilherme B. Gramcianinov, Pamela Z. Jorge, Vanessa B. Malaquias, Augusto A. Mori, Mário H. Hirata, et al. (+4)
9 [GO] 2023―Feb―07 Qualitative and quantitative determination of chemical constituents in Jinbei oral liquid, a modern Chinese medicine for coronavirus disease 2019, by ultra-performance liquid chromatography coupled with mass spectrometry Aijun Zhang, Qingcui Xu, Juanjuan Jiang, Zimo Zhao, Liangzong Zhang, Kai Tao, et al. (+6)
10 [GO] 2023―Jan―26 Interaction of copper potential metallodrugs with TMPRSS2: A comparative study of docking tools and its implications on COVID-19 Sergio Vazquez-Rodriguez, Diego Ramírez-Contreras, Lisset Noriega, Amalia García-García, Brenda L. Sánchez-Gaytán, Francisco J. Melendez, et al. (+3)
11 [GO] 2023―Jan―24 Computational investigation on the antioxidant activities and on the Mpro SARS-CoV-2 non-covalent inhibition of isorhamnetin Maciej Spiegel, Giada Ciardullo, Tiziana Marino, Nino Russo
12 [GO] 2023―Jan―12 Inhibitory effect of phytochemicals towards SARS-CoV-2 papain like protease (PLpro) proteolytic and deubiquitinase activity Anasha Kawall, Devin S. M. Lewis, Avini Sharma, Krishna Chavada, Rahul Deshmukh, Srujana Rayalam, et al. (+2)
13 [GO] 2022―Dec―08 Identification of potential inhibitors of omicron variant of SARS-Cov-2 RBD based virtual screening, MD simulation, and DFT Xudong Lü, Cuiyue Feng, Ruijie Lü, Xiyu Wei, Shuai Fan, Maocai Yan, et al. (+3)
14 [GO] 2022―Dec―06 Therapeutic potential of compounds targeting SARS-CoV-2 helicase Matthew T. J. Halma, Mark J. A. Wever, Sanne Abeln, Didier Roche, Gijs J. L. Wuite
15 [GO] 2022―Oct―31 Identification and characterization of alternative sites and molecular probes for SARS-CoV-2 target proteins Suhasini M. Iyengar, Kelly K. Barnsley, Hoang Yen Vu, Ian Jef A. Bongalonta, Alyssa S. Herrod, Jasmine A. Scott, Mary Jo Ondrechen
16 [GO] 2022―Oct―24 Structural similarities between SARS-CoV2 3CLpro and other viral proteases suggest potential lead molecules for developing broad spectrum antivirals Khushboo Bafna, Christopher L. Cioffi, Robert M. Krug, Gaetano T. Montelione
17 [GO] 2022―Oct―11 Discovery of putative inhibitors against main drivers of SARS-CoV-2 infection: Insight from quantum mechanical evaluation and molecular modeling Toheeb A. Balogun, Onyeka S. Chukwudozie, Uchechukwu C. Ogbodo, Idris O. Junaid, Olugbodi A. Sunday, Oluwasegun M. Ige, et al. (+17)
18 [GO] 2022―Oct―05 Druggable targets and therapeutic development for COVID-19 Xiaohua Duan, Lauretta A. Lacko, Shuibing Chen
19 [GO] 2022―Jul―12 An Efficient Modern Strategy to Screen Drug Candidates Targeting RdRp of SARS-CoV-2 With Potentially High Selectivity and Specificity Haiping Zhang, Xiaohua Gong, Yun Peng, Konda Mani Saravanan, Hengwei Bian, John Z. H. Zhang, et al. (+3)
20 [GO] 2022―Jun―08 Deciphering the Impact of Mutations on the Binding Efficacy of SARS-CoV-2 Omicron and Delta Variants With Human ACE2 Receptor Alamgir Khan, Salman Ali Khan, Komal Zia, Mezna Saleh Altowyan, Assem Barakat, Zaheer Ul-Haq
21 [GO] 2022―Apr―26 Inhibitors of SARS-CoV-2 PLpro Dale J. Calleja, Guillaume Lessene, David Komander
22 [GO] 2022―Apr―12 Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors Dale J. Calleja, Nathan Kuchel, Bernadine G. C. Lu, Richard W. Birkinshaw, Theresa Klemm, Marcel Doerflinger, et al. (+19)
23 [GO] 2022―Apr―11 Hydrazones and Thiosemicarbazones Targeting Protein-Protein-Interactions of SARS-CoV-2 Papain-like Protease Wiebke Ewert, Sebastian Günther, Francesca Miglioli, Sven Falke, Patrick Y. A. Reinke, Stephan Niebling, et al. (+12)
24 [GO] 2022―Feb―24 Crystallization of Feline Coronavirus Mpro With GC376 Reveals Mechanism of Inhibition Jimmy Lu, Sizhu Amelia Chen, Muhammad Bashir Khan, Raelynn Brassard, Elena Arutyunova, Tess Lamer, et al. (+5)
25 [GO] 2022―Feb―23 Potential Inhibitors Targeting Papain-Like Protease of SARS-CoV-2: Two Birds With One Stone Haihai Jiang, Peiyao Yang, Jin Zhang
26 [GO] 2022―Feb―17 An Enhanced Hybrid Screening Approach to Identify Potent Inhibitors for the SARS-CoV-2 Main Protease From the NCI Compound Library Shuhua G. Li, Kai S. Yang, Lauren R. Blankenship, Chia-Chuan D. Cho, Shiqing Xu, Hongbin Wang, Wenshe Ray Liu
27 [GO] 2022―Feb―10 Natural Products and Nanotechnology Against Coronavirus Disease 2019 Ning Zeng, Xue Chen, Zeming Liu
28 [GO] 2022―Feb―04 Corrigendum: Inhibition of SARS-CoV-2 by Targeting Conserved Viral RNA Structures and Sequences Shalakha Hegde, Zhichao Tang, Junxing Zhao, Jingxin Wang
29 [GO] 2022―Feb―03 Targeting SARS-CoV-2 Proteases for COVID-19 Antiviral Development Zongyang Lv, Kristin E. Cano, Lijia Jia, Marcin Drag, Tony T. Huang, Shaun K. Olsen
30 [GO] 2022―Feb―01 In Planta Production of the Receptor-Binding Domain From SARS-CoV-2 With Human Blood Group A Glycan Structures Julia König-Beihammer, Ulrike Vavra, Yun-Ji Shin, Christiane Veit, Clemens Grünwald-Gruber, Yasmin Gillitschka, et al. (+6)
31 [GO] 2021―Dec―28 Repurposing of Drugs for SARS-CoV-2 Using Inverse Docking Fingerprints Marko Jukič, Katarina Kores, Dušanka Janežič, Urban Bren
32 [GO] 2021―Dec―23 Inhibition of SARS-CoV-2 by Targeting Conserved Viral RNA Structures and Sequences Shalakha Hegde, Zhichao Tang, Junxing Zhao, Jingxin Wang
33 [GO] 2021―Nov―19 Site-Specific Glycosylation Patterns of the SARS-CoV-2 Spike Protein Derived From Recombinant Protein and Viral WA1 and D614G Strains Yuan Tian, Lisa M. Parsons, Ewa Jankowska, John F. Cipollo
34 [GO] 2021―Oct―10 Inhibition Potencies of Phytochemicals Derived from Sesame Against SARS-CoV-2 Main Protease: A Molecular Docking and Simulation Study Anuj Kumar, Dwijesh Chandra Mishra, Ulavappa Basavanneppa Angadi, Rashmi Yadav, Anil Rai, Dinesh Kumar
35 [GO] 2021―Oct―01 Machine Learning of Serum Metabolic Patterns Encodes Asymptomatic SARS-CoV-2 Infection Qiongqiong Wan, Moran Chen, Zheng Zhang, Yu Yuan, Hao Wang, Yanhong Hao, et al. (+3)
36 [GO] 2021―Sep―28 Characterization of Phytochemicals in Ulva intestinalis L. and Their Action Against SARS-CoV-2 Spike Glycoprotein Receptor-Binding Domain Seema A. Kulkarni, Sabari B.B. Krishnan, Bavya Chandrasekhar, Kaushani Banerjee, Honglae Sohn, Thirumurthy Madhavan
37 [GO] 2021―Sep―27 Structure-Based Virtual Screening and Identification of Potential Inhibitors of SARS-CoV-2 S-RBD and ACE2 Interaction Jiacheng Xiong, Yusen Xiang, Ziming Huang, Xiaohong Liu, Mengge Wang, Guangbo Ge, et al. (+4)
38 [GO] 2021―Sep―24 A Linkage-specific Sialic Acid Labeling Strategy Reveals Different Site-specific Glycosylation Patterns in SARS-CoV-2 Spike Protein Produced in CHO and HEK Cell Substrates Qiong Wang, Yan Wang, Shuang Yang, Changyi Lin, Lateef Aliyu, Yiqun Chen, et al. (+6)
39 [GO] 2021―Sep―10 Changes in Glycolytic Pathway in SARS-COV 2 Infection and Their Importance in Understanding the Severity of COVID-19 Adalberto Fernandes Santos, Pedro Póvoa, Paulo Paixão, António Mendonça, Luís Taborda-Barata
40 [GO] 2021―Sep―06 O-Glycosylation Landscapes of SARS-CoV-2 Spike Proteins Yong Zhang, Wanjun Zhao, Yonghong Mao, Yaohui Chen, Shanshan Zheng, Wei Cao, et al. (+5)
41 [GO] 2021―Sep―03 Editorial: Molecular Studies of Covid-19 Chemistry Domenica Capasso, Sonia Di Gaetano, Chandrabose Selvaraj, Emilia Pedone
42 [GO] 2021―Jul―22 Identification of Potential Binding Sites of Sialic Acids on the RBD Domain of SARS-CoV-2 Spike Protein Bingqian Li, Lin Wang, Huan Ge, Xianglei Zhang, Penxuan Ren, Yu Guo, et al. (+6)
43 [GO] 2021―Jun―24 Catalytic Dyad Residues His41 and Cys145 Impact the Catalytic Activity and Overall Conformational Fold of the Main SARS-CoV-2 Protease 3-Chymotrypsin-Like Protease Juliana C. Ferreira, Samar Fadl, Adrian J. Villanueva, Wael M. Rabeh
44 [GO] 2021―May―10 Pharmacophore Modelling-Based Drug Repurposing Approaches for SARS-CoV-2 Therapeutics Shailima Rampogu, Keun Woo Lee
45 [GO] 2021―May―04 Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor Ahmed A. Al-Karmalawy, Mohammed A. Dahab, Ahmed M. Metwaly, Sameh S. Elhady, Eslam B. Elkaeed, Ibrahim H. Eissa, Khaled M. Darwish
46 [GO] 2021―Apr―28 Pomegranate Peel Extract as an Inhibitor of SARS-CoV-2 Spike Binding to Human ACE2 Receptor (in vitro): A Promising Source of Novel Antiviral Drugs Annalisa Tito, Antonio Colantuono, Luciano Pirone, Emilia Pedone, Daniela Intartaglia, Giuliana Giamundo, et al. (+3)
47 [GO] 2021―Mar―29 Antiviral Essential Oil Components Against SARS-CoV-2 in Pre-procedural Mouth Rinses for Dental Settings During COVID-19: A Computational Study Pradeep Kumar Yadalam, Kalaivani Varatharajan, K. Rajapandian, Priyanka Chopra, Deepavalli Arumuganainar, Thilgavathi Nagarathnam, et al. (+2)
48 [GO] 2021―Mar―12 Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease Hylemariam Mihiretie Mengist, Tebelay Dilnessa, Tengchuan Jin
49 [GO] 2021―Feb―07 In Silico Study of Coumarins and Quinolines Derivatives as Potent Inhibitors of SARS-CoV-2 Main Protease Osvaldo Yañez, Manuel Isaías Osorio, Eugenio Uriarte, Carlos Areche, William Tiznado, José M. Pérez-Donoso, et al. (+2)
50 [GO] 2021―Feb―04 In silico Exploration of Inhibitors for SARS-CoV-2's Papain-Like Protease Tien Huynh, Wendy Cornell, Binquan Luan
51 [GO] 2021―Jan―21 Computational Characterizations of the Interactions Between the Pontacyl Violet 6R and Exoribonuclease as a Potential Drug Target Against SARS-CoV-2 Rangika Munaweera, Ying S. Hu
52 [GO] 2021―Jan―14 Microsecond MD Simulation and Multiple-Conformation Virtual Screening to Identify Potential Anti-COVID-19 Inhibitors Against SARS-CoV-2 Main Protease Chandrabose Selvaraj, Umesh Panwar, Dhurvas Chandrasekaran Dinesh, Evzen Boura, Poonam Singh, Vikash Kumar Dubey, Sanjeev Kumar Singh
53 [GO] 2021―Jan―13 Structural Insight Into the SARS-CoV-2 Nucleocapsid Protein C-Terminal Domain Reveals a Novel Recognition Mechanism for Viral Transcriptional Regulatory Sequences Mei Yang, Suhua He, Xiaoxue Chen, Zhaoxia Huang, Ziliang Zhou, Zhechong Zhou, et al. (+3)
54 [GO] 2021―Jan―05 Elucidating Interactions Between SARS-CoV-2 Trimeric Spike Protein and ACE2 Using Homology Modeling and Molecular Dynamics Simulations Sugunadevi Sakkiah, Wenjing Guo, Bohu Pan, Zuowei Ji, Gokhan Yavas, Marli Azevedo, et al. (+3)
55 [GO] 2020―Dec―23 Computational Prediction of Potential Inhibitors of the Main Protease of SARS-CoV-2 Renata Abel, María Paredes Ramos, Qiaofeng Chen, Horacio Pérez-Sánchez, Flaminia Coluzzi, Monica Rocco, et al. (+6)
56 [GO] 2020―Dec―10 Host DDX Helicases as Possible SARS-CoV-2 Proviral Factors: A Structural Overview of Their Hijacking Through Multiple Viral Proteins Flavia Squeglia, Maria Romano, Alessia Ruggiero, Giovanni Maga, Rita Berisio
57 [GO] 2020―Dec―08 Identification of Small Molecule Inhibitors of the Deubiquitinating Activity of the SARS-CoV-2 Papain-Like Protease: in silico Molecular Docking Studies and in vitro Enzymatic Activity Assay Eleni Pitsillou, Julia Liang, Katherine Ververis, Kah Wai Lim, Andrew Hung, Tom C. Karagiannis
58 [GO] 2020―Nov―19 Screening of Natural Products Targeting SARS-CoV-2-ACE2 Receptor Interface - A MixMD Based HTVS Pipeline Krishnasamy Gopinath, Elmeri M. Jokinen, Sami T. Kurkinen, Olli T. Pentikäinen
59 [GO] 2020―Nov―16 Repurposing Known Drugs as Covalent and Non-covalent Inhibitors of the SARS-CoV-2 Papain-Like Protease Pietro Delre, Fabiana Caporuscio, Michele Saviano, Giuseppe Felice Mangiatordi
60 [GO] 2020―Nov―05 Supporting SARS-CoV-2 Papain-Like Protease Drug Discovery: In silico Methods and Benchmarking Tamer M. Ibrahim, Muhammad I. Ismail, Matthias R. Bauer, Adnan A. Bekhit, Frank M. Boeckler
61 [GO] 2020―Oct―30 Identification of a New Potential SARS-COV-2 RNA-Dependent RNA Polymerase Inhibitor via Combining Fragment-Based Drug Design, Docking, Molecular Dynamics, and MM-PBSA Calculations Mahmoud A. El Hassab, Aly A. Shoun, Sara T. Al-Rashood, Tarfah Al-Warhi, Wagdy M. Eldehna
62 [GO] 2020―Oct―23 Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain Adriana Carino, Federica Moraca, Bianca Fiorillo, Silvia Marchianò, Valentina Sepe, Michele Biagioli, et al. (+7)
63 [GO] 2020―May―27 Development of Point-of-Care Biosensors for COVID-19 Jane Ru Choi
 [1] 

63 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.008 sec